ALTality, Inc.

ALTality, Inc. , based in Ann Arbor, Michigan, specializes in augmented reality solutions that enhance the pediatric healthcare experience through interactive educational tools designed to engage and distract young patients during treatment. Founded in 2016 in Ann Arbor, Michigan, ALTality, Inc. develops innovative tools for healthcare environments focused on pediatric patients.

Christina York and Leonardo Jacques are the co-founders. In May 2020, the company raised USD 0. 15 million in Seed funding from Jumpstart Health Investors, bringing the total amount raised to USD 0. 15 million with a current valuation of USD 4.

00 mn. SpellBound AR specializes in enhancing the pediatric patient experience through a suite of innovative educational and distraction tools designed for healthcare environments. Their core product offerings include augmented reality games and educational resources tailored to engage pediatric patients during various stages of their healthcare journey. Key products, such as ARISE, integrate movement-based therapy, encouraging children to actively participate in their recovery process.

SpellBound AR serves a diverse clientele, including hospitals, pediatric clinics, and healthcare organizations across North America and Europe. SpellBound AR generates revenue primarily through B2B partnerships with healthcare organizations, enabling them to integrate its tools into patient care protocols. The company’s transaction structure includes subscription agreements for ongoing access to its digital tools and one-time licensing fees for specific applications, which allow healthcare providers to effectively utilize SpellBound's offerings while establishing a steady revenue stream. ALTality, Inc.

plans to leverage its recent funding of USD 0. 15 million raised in May 2020 to further develop its product portfolio and enhance its market presence. The company is designing new augmented reality applications aimed at improving patient engagement and reducing anxiety during medical procedures. ALTality, Inc.

also aims to expand its reach within North America and into select European markets by the end of 2022, targeting partnerships with additional healthcare institutions to broaden the accessibility of its innovative solutions.